Medifast, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $202.5M | $104.2M |
| FY2022 | — | $155.0M | $87.7M |
| FY2023 | — | $201.5M | $94.4M |
| FY2024 | — | $210.1M | $90.9M |
| FY2025 | — | $198.9M | $89.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $202.5M | $104.2M |
| FY2022 | — | $155.0M | $87.7M |
| FY2023 | — | $201.5M | $94.4M |
| FY2024 | — | $210.1M | $90.9M |
| FY2025 | — | $198.9M | $89.3M |